David F. Moreno - Concepedia

Author

David F. Moreno

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer ORCID

Also Known As

D Moreno, D. Moreno, D.F. Moreno, David F Moreno, David F. Barrero Moreno, David F. Moreno, David Fernando Moreno, David Moreno, David Moreno (527989)

159

Publications

594

Citations

H-Index

Concepts

All Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Hospital Clínic de Barcelona Universitat de Barcelona Universidad de Alcalá Centro de Investigación del Cáncer

About

David F. Moreno is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in medicine, parasitology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	143
2	Natural Sciences	1	1	46
3	Biology	1	1	54
4	Cell Biology	1	1	26
5	Immunology	1	1	26

David F. Moreno

Publications

344

Citations

H-Index

Page 1

	Year	Citations
Leishmania infantum expresses a mitochondrial nuclease homologous to EndoG that migrates to the nucleus in response to an apoptotic stimulus Eva Rico, Juan F. Álzate, Andrés A. Arias, Molecular and Biochemical Parasitology BiologyParasitic ProtozoaLeishmania InfantumGeneticsMitochondrial Nuclease	2008	54
Antileishmanial activity of imidothiocarbamates and imidoselenocarbamates David F. Moreno, Daniel Plano, Ylenia Baquedano, Parasitology Research Medicinal ChemistryBioorganic ChemistryAntileishmanial ActivityAntiparasitic AgentMedicine	2010	46
First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma Aina Oliver‐Caldés, Raquel Jiménez, Marta Español‐Rego, Journal for ImmunoTherapy of Cancer	2021	45
Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution Raquel Jiménez‐Segura, Laura Rosiñol, Ma Teresa Cibeira, Blood Cancer Journal	2022	35
Probing the Dimerization Interface of <i>Leishmania infantum</i> Trypanothione Reductase with Site‐Directed Mutagenesis and Short Peptides Miguel Toro-Londoño, Pedro A. Sánchez‐Murcia, David F. Moreno, ChemBioChem	2013	26
Prognostic impact of <i><scp>MYD88</scp></i> and <i><scp>CXCR4</scp></i> mutations assessed by droplet digital polymerase chain reaction in <scp>IgM</scp> monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia David F. Moreno, Mònica López‐Guerra, Sara Paz, British Journal of Haematology ImmunodeficienciesGeneticsImmunologyPathologyBm Infiltration	2022	26
Efficacy and safety of one‐day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft‐versus‐host disease Joan Cid, Gloria Carbassé, María Suárez‐Lledó, Transfusion	2019	24
Real‐world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45‐year period Luis Gerardo Rodríguez‐Lobato, Arturo Pereira, Carlos Fernández de Larrea, British Journal of Haematology Hematological MalignancyPrognostic EvaluationOncologyTransplantationReal‐world Data	2021	17
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma Aina Oliver‐Caldés, Marta Español‐Rego, Aintzane Zabaleta, Clinical Cancer Research	2024	16
Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients Luis Gerardo Rodríguez‐Lobato, Alexandra Martínez‐Roca, David F. Moreno, Leukemia & lymphoma/Leukemia and lymphoma	2020	12

Page 1